Objective To explore the interventional therapeutic methods for hepatocelular carcinoma accompanied with arteriovenous shunt. Methods 34 cases with proved hepatocelular carcinoma(HCC) were underwent DSA firstly, judge whether to exist Hepatic arterial-portal venous shunts. then transcatheter arterial chemoembolization (TACE) or transcatheter arterial infusion (TAI) were performed in al cases . we compared with the therapeutic effect of TACE with the one of TAI. Results Totaly 11 cases were presented with arteriovenous shunt, including 6 cases with hepatic artery-portal vein shunts of central type, 4 cases with the ones of peripheral type, 1 cses with the ones of mixed type. Hepatic function was improved after interventional therapy. The median survival time,two months survival rate, six months survival rate and one year survival rate of the case received TACE were higher than the cases received TAI. The ones of huge hepatic carcinoma and nodulous hepatic carcinoma were higher than the ones of asystematic hepatic carcinoma. The ones of huge hepatic carcinoma were similar with the ones of nodulous hepatic carcinoma. Conclusion The blockings of hepatic artery-portal vein shunts of peripheral type, are easier than the ones of central type. When we succeed to blocking the hepatic artery-portal vein shunts and use micro catheter to bypass the hepatic artery-portal vein shunts , TACE is used but the hepatic artery-portal vein shunts has to be treated with TAI only.
NETL
NSTL
万方数据
